Narcolepsy |
|
|
Narcolepsy is a neurological condition most characterized by Excessive Daytime Sleepiness (EDS), episodes of sleep and disorder of REM or rapid eye movement sleep. It is a kind of dyssomnia. Symptoms of narcolepsy The main characteristic of narcolepsy is overwhelming excessive daytime sleepiness (EDS), even after adequate nighttime sleep. A person with narcolepsy is likely to become drowsy or to fall asleep, often at inappropriate times and places. Daytime naps may occur with or without ...
Wikipedia - [full article]
Narcolepsy Clinical Trials
- Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
ClinicalTrials.gov Identifier: NCT00132873 - Recruiting
Narcolepsy
- A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy
ClinicalTrials.gov Identifier: NCT00424931 - Recruiting
Narcolepsy
- Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
ClinicalTrials.gov Identifier: NCT00366080 - Recruiting
Narcolepsy
- Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
ClinicalTrials.gov Identifier: NCT00244465 - Recruiting
Narcolepsy
- Trial Comparing Effects of Xyrem taken Orally and Modafinil with Placebo in Treating Daytime Sleepiness in Narcolepsy
ClinicalTrials.gov Identifier: NCT00066170 - Completed
Narcolepsy
- Body Weight Regulation in Patients With Narcolepsy
ClinicalTrials.gov Identifier: NCT00283894 - Not yet recruiting
Narcolepsy
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
ClinicalTrials.gov Identifier: NCT00107796 - Completed
Narcolepsy
- Safety and Efficacy Study of CEP-10953 in the Treatment of Excessive Sleepiness Associated with Narcolepsy
ClinicalTrials.gov Identifier: NCT00078377 - Completed
Narcolepsy
- PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
ClinicalTrials.gov Identifier: NCT00107848 - Completed
Narcolepsy; Sleep Apnea, Obstructive
- Sleep Disorders of Patients with Diseases of the Nervous System
ClinicalTrials.gov Identifier: NCT00001664 - Recruiting
Hypersomnia; Narcolepsy; Nervous System Disease; Sleep Disorder
- Safety and efficacy of Xyrem oral solution (sodium oxybate) compared with placebo in narcoleptic patients
ClinicalTrials.gov Identifier: NCT00049803 - Completed
Narcolepsy
- Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
ClinicalTrials.gov Identifier: NCT00345800 - Recruiting
Narcolepsy With Cataplexy
- Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and and Neurocognition
ClinicalTrials.gov Identifier: NCT00484757 - Recruiting
Narcolepsy
- Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
ClinicalTrials.gov Identifier: NCT00228566 - Completed
Excessive Day Time Sleepiness; Narcolepsy
- CEP-10953 for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
ClinicalTrials.gov Identifier: NCT00078312 - Completed
Narcolepsy; Sleep Apnea, Obstructive; Sleep Apnea Syndromes; Shift-Work Sleep Disorder
- Provigil (Modafinil) Study by Taiwan Biotech Co.
ClinicalTrials.gov Identifier: NCT00174174 - Completed
Narcolepsy; Cataplexy; Sleep Disorders; Hypersomnolence; Excessive Sleepiness
- Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
ClinicalTrials.gov Identifier: NCT00214968 - Completed
Excessive Daytime Sleepiness; Narcolepsy
- Extension Study of the Safety and Efficacy of CEP-10953 in the Treatment of Patients With Excessive Sleepiness
ClinicalTrials.gov Identifier: NCT00228553 - Completed
Excessive Daytime Sleepiness; Narcolepsy

Not Signed In -


